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Retinoblastoma is a malignant intraocular neoplasm in pediatric which composed of embyonic 
tumour cells from retinoblasts of neuroepithelial origin with a relative incidence of 3% of all 
pediatric tumours. Histopathology examination can confirmed the diagnosis of retinoblastoma. 
Immunohistochemical staining with C-kit antibody can be used to identify the expression of C-kit 
in paraffin block of retinoblastoma sample.This study was conducted to identify C-kit expresion 
in various degrees of histopathology differentiation’s retinoblastoma in Mohammad Hoesin 
Hospital Palembang.. A descriptive study used on the paraffin blocks of 19 cases retinoblastoma 
in RSUP dr. Mohammad Hoesin from January 2012- July 2017. The degree of histopathologic 
differentiation and invasion of retinoblastoma was investigated by Hematoksilin-Eosin stain, and 
the C-kit expression stained by immunohistochemistry using antibody C-kit ready to use. Data 
was being presented in tabular form to identify C-kit expression. Retinoblastoma which expressed 
C-kit in this study are 63,16% among all sample. C-kit expressions were detected in 25% well 
differentiated, 50 % moderately differentiated, and 25% poorly differentiated of histopathological 
differentiation degree, also in 50% sample with optic nerve invasion and 58,33% in scleral 
invasion. C-kit expression was negative in 36,84% sample. In this study, C-kit expression was 
found more than half in retinoblastoma sample. 
Keyword: C-kit, degree of histopathology differentiation, retinoblastoma 
1. INTRODUCTION 
 
Retinoblastoma is a primary intraocular 
malignant tumor in children whose tumor 
cells derived from embryonic retinoblast of 
neuroepitel structure are biologically similar 
to neuroblastoma and medulloblastoma. 1-4  
The incidence of retinoblastoma is 3% of all 
childhood tumors.1-3 Based on data obtained 
from the pedoatric hemato-oncology  at 
RSCM 2010-2016, retinoblastoma incidence 
was 156 cases and was the second most 
common malignancy after acute lymphocytic 
leukemia.7 Data from the pediatric hemato-
oncology Dr. Hospital Mohammad Hoesin 
Palembang reported retinoblastoma cases as 
many as 37 cases calculated from the year 
2008-2014.8 Precise diagnosis of 
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retinoblastoma confirmed by histopathology 
examination. 2,3,9   Youssef et al (2014) 
classified three degrees of differentiation of 
retinoblastoma, consist of well differentiated, 
moderately differentiated and poorly 
differentiated.1 
Retinoblastoma’s pattern of growth was 
studied in many research centers and found 
involvement of molecular processes in the 
case. Some specific proteins are known to be 
involved in the developmental process of 
retinoblastoma, and one of them is the 
CD117 protein otherwise known as C-kit. 
This protein is encoded by the Kit gene, a 
human proto-oncogen located on the long 
arm of chromosome 4 q11-21. This gene 
encodes a 145 kDa transmembrane protein of 
tyrosine kinase, a protein that acts as a type 
III tyrosine kinase receptor. These receptors 
form complexes with SCF ligands (stem cell 
factors) and induce cellular processes such as 
cell proliferation, migration and 
differentiation.1,10-14 
The role of C-kit has been found in more 
than 120 types of tumors by using 
immunohistochemical methods on TMA 
(tissue microarray). C-kit is generally found 
to be positive in GIST (Gastrointestinal 
Stromal Tumor), but in some other tumors 
also found positive C-kit expression. 1,10,11,13-
15 
Bosch et al (2005) conducted a study of 
immunostaining with C-kit antibodies in 73 
retinoblastoma cases. The results found 
positive expression in 14 cases of 19.2%.11 
The interesting thing about this protein is the 
potential for the development of cancer 
therapy targeting the C-kit protein. 1,11,14,15 
A study conducted by Barry et al (2007) 
showed that 52.38% of cases of 
retinoblastoma express C-kit on 
immunohistochemical examination.10 
Youssef et al (2014) conducted a C-kit 
expression study on retinoblastoma and 
obtained positive C-kit results as much as 
48.2%. Immunoreactivity is associated with 
invasion of the sclera and optic nerve and 
may represent more invasive 
retinoblastoma.1,10 
The prognosis is influenced by various 
factors including the extent of tumor invasion 
into the structure of the globe and optic 
nerve.1,2,16,17 Looking at the magnitude of 
retinoblastoma morbidity and mortality rates 
and taking into account the absence of data 
on C-kit expression in retinoblastoma cases 
in Indonesia , this study was conducted to 
identify C-kit expression in different degrees 
of histopathologic differentiation and 
invasion of retinoblastoma at Dr. Mohammad 




This study is a descriptive study to 
identify C-kit expression in various degrees 
of retinoblastoma histopathologic 
differentiation by immunohistochemical 
examination of retinoblastoma tissue samples 
at Dr. Mohammad Hoesin General Hospital 
Palembang. This research was conducted at 
Eye Polyclinic and Anatomical Pathology 
Laboratory of Dr. Mohammad Hoesin 
General Hospital Palembang from January 
2017 until July 2017. The target population 
was all retinoblastoma patients who went to 
the Dr. Mohammad Hoesin Palembang who 
had and will do surgical removal of the 
tumor. The research sample is determined by 
time-based method. The subjects of the study 
were retinoblastoma patients who came to the 
Eye Polyclinic of Dr. Mohammad Hoesin 
General Hospital Palembang which has been 
and will be carried out surgical removal of the 
tumor and has been given informed consent 
and signed the agreement in the period 
January 2017 to July 2017 and preparations 
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histopathology retinoblastoma from January 
2012 to December 2016.  
Sample recruitment criteria: The sample 
in this study is the population that meets the 
acceptance criteria for the research sample. 
The Inclusion criteria were (a) All 
retinoblastoma patients who seek treatment at 
Eye Polyclinic of Dr. Mohammad Hoesin 
General Hospital Palembang. (b)The 
preparation is derived from surgical measures 
containing retinoblastoma tumor tissue. (c) 
Histopathological preparations are in good 
condition or eligible for 
immunohistochemical examination. (d) 
Willing to follow the research stated by 
signing informed consent (for new cases / 
primary data). The Exclusion criteria were: 
(a) Postoperative, after histopathological 
examination did not show Retinoblastoma (b) 
Suspected Retinoblastoma patients (patients 
died or delayed surgery) during the period 
from January 2017 to July 2017. Sampling is 
done by total sampling technique. Patients 
suspected retinoblastoma that meet the 
criteria of inclusion were informed consent, 
ophthalmological and auxiliary examination. 
Histopathological preparations of 
retinoblastoma that meet the inclusion 
criteria are taken as samples to meet the 
specified sample size. The degree of 
histopathologic differentiation of 
retinoblastoma is classified as follows:  
a. Well differentiated: Flexner-
Wintersteiner rosettes or fleurettes are 
found. 
b. Moderately differentiated: The tumor 
consists of isolated Homer-Wright 
rosettes. 
c. Poorly differentiated: Flexner-
Wintersteiner rosettes and Homer-
Wright rosettes are not found. 
 
Expression C-kit is an expression of 
receptor tyrosine kinase that is inserted on 
immunohistochemical examination by using 
C-kit primary antibody. The cells are rated in 
10 large fields. The coloring results are 
categorized into four groups. Tumors in the 
absence of staining are called negatives. 
Tumors with 1+ staining on <60% cells and 
2+ staining at <30% intensity are relatively 
weak. Tumors with 1+ staining at >60% cell 
intensity, 2+ staining at 30-79%, or 3+ on 
<30% cells are considered moderate. 
Positively strong if tumor with intensity 2+ 




This study is a descriptive study to 
identify C-kit expression in various degrees 
of histopathologic differentiation and 
invasion of retinoblastoma. This research 
was conducted at Eye Polyclinic and 
Department of Anatomy of Dr. Mohammad 
Hoesin General Hospital Palembang. 
Samples in this study were paraffin block 
preparations taken from retinoblastoma 
patients who were referred and went to Eye 
Polyclinic of RSUP Mohammad Hoesin 
Palembang which had been and will be 
carried out surgery action in the research 
period and confirmed histopathologically 
then done immunohistochemical staining.  
There were 24 retinoblastoma patients 
recorded at RSMH Palembang during the 
period of January 2012-July 2017. Of these 
24 patients, 4 of which paraffin blocks were 
not available for immunohistochemical 
staining and 1 paraffin block did not have 
sufficient tissue count for 
immunohistochemical readings, the number 
of samples meeting the inclusion criteria in 
this study were 19 samples. General 
characteristics of the subjects in this study 
include the sex, age and laterality of the 
tumor. 
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Table 1. General Characteristics of Research Subjects 
Characteristics n % 
Sex   
Boys 11 57,89 
Girls 8 42,11 
Age   
     Youngest 
     Oldest 
     Mean (SD) 
     Median (Min-Max) 
0 year 
8 years 
3 (2,4) years 
3 (0 – 8 years) 
 
Tumor Lateralitity   
Unilateral :   
Right eye 10 52,63 
Left eye 7 36,84 
Bilateral 2 10,53 
Total 19 100,00 
 
Based on table 1, samples suffering from retinoblastoma were mostly male (57,89%), and 
samples suffering from female retinoblastoma were 8 samples (42.11%). In terms of age, the 
average sample suffering from retinoblastoma is 3 years with the youngest age suffering from 
retinoblastoma is 2 months but categorized in 0 years and the oldest age of samples suffering from 
retinoblastoma is 8 years. When studied further, as many as 68.42% of the total sample suffered 
from retinoblastoma at <3 years old. Retinoblastoma can occur unilaterally or bilaterally. Table 1 
also presents data on retinoblastoma laterality. Of the total 19 samples, 17 samples suffered from 
unilateral retinoblastoma (89.47%) and 2 samples (10.53%) suffered from bilateral retinoblastoma. 
 
Table 2. Histopathological Sample Features 
Degree of differentiation n % 
Well 3 15.79 
Moderate 13 68..42 
Poor 3 15..79 
Optic nerve invasion n % 
Positive 12 63.16 
Negative 4 21.05 
Difficult to determined 3 15.79 
Sclera invasion n % 
Positive 11 57.89 
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Negative 8 42.11 
 
In this study, we assessed a 
histopathologic feature of a sample 
consisting of degrees of differentiation and 
invasion. Most samples were categorized as 
moderately differentiated, as many as 13 
samples (68.42%) and there were 3 well 
differentiated samples (15.79%) and 3 other 
samples categorized as poorly differentiated 
(15.79%). In this study, 12 samples of 
retinoblastoma were invasive to the optic 
nerve (63.16%). A total of 21.05% or 4 
samples showed no invasion to the optic 
nerve and 3 samples (15.79%) of the invasion 
were difficult to determined. And 11 samples 
of retinoblastoma were invasive to sclera 
(57.89%) and no invasion in 8 samples was 
42.11%. In this study showed positive C-kit 
expression on 12 samples (63,16%) and 7 
samples with negative C-kit expression 
(36,84%). Based on table 3, the results of 
positive C-kit expression were classified 
based on differentiation degree of well-
differentiated by 3 samples from total of 12 
samples (25.0%), moderately differentiated 
as many as 6 cases (50.0%) and poorly 
differentiated as many as 3 cases (25.0%). 
For negative C-kit expression results, the 
overall sample was classified as moderate 
differentiation (100%). In the sample with 
positive C-kit expression, the result of 
positive weak coloring category was 41.67% 
and moderate was 58.33%. 
 
 
Table 3. Expression of C-kit on Differentiation Degree of Retinoblastoma Histopathology  
   and various intensities and cell proportions 
C-kit Expression 
Degree of Differentiation 
Well  Moderate  Poor 
n %  n %  n % 
Positive 3 25%  6 50%  3 25% 
Negative 0 0%  7 100%  0 0% 
 
 
Intensities and cell proportions 
Negative  Weak Positivity  Moderate Positivity 
n %  n %  n % 
Postive 0 0  5 41.67  7 58.33 
Negative 7 100  0 0  0 0 
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This picture below shows us the results of histopathology and immunohistochemical 
examination : 
 
Figure 1. Results of Histopathology and Immunohistochemical Examination A. Sample Histopathological Examination No. 9 with 3071 / A / 2015 
(Well-differentiated) availability. Hematoxylin-Eosin staining, 400x magnification. B. Examination of Immunohistochemical samples No.9 
Expression of C-kit (+) with weak positive intensity. 100x magnification. C. Histopathological Examination of sample No.12 with no.supplies 3771 
/ A / 2014 (Moderately-differentiated). Hematoxylin-Eosin staining, 400x magnification. D. Immunohistochemical examination of sample No.12 
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Expression C-kit (+) with moderate positive intensity 100x magnification. E. Sample Histopathological Examination No. 2 with no.supply 506 / A 
/ 2017 (Poorly-differentiated). Hematoxylin-Eosin staining, 400x magnification. 
Here we present a histopathological picture of retinoblastoma with invasion to the optic 




Figure 2. Histopathological Examination Result  
F. Invasion of optic nerve  
G. Sclera invasion on sample no.4 (1086/A/2016). Hematoxylin-Eosin staining, 40x magnification 
 
 
4. DISCUSSION  
 
Based on sex, the incidence of 
retinoblastoma in this study was 57,89% 
sample of male and female sex of 42,11%. 
The American Academy of Ophthalmology 
reports that there is no sex predilection for 
retinoblastoma. The incidence of 
retinoblastoma is reported almost the same 
among men and women. Research conducted 
by Youssef et al reported the incidence of 
retinoblastoma occurred in 57.1% of women 
and 42.9% occurred in men. This study was 
slightly different from that of Bosch et al 
reported in 95 immunohistochemical 
retinoblastoma samples, a sample of 29 
males, 56 females and 9 samples of 
unrecognized gender. When viewed from the 
data above, the incidence of occurrence in 
women more.1,2,11 
Most of the subjects of this study 
were 0-3 years old as much as 68.42% and 
over 3 years age of 31.58%. The mean age of 
the samples in this study who suffered from 
retinoblastoma was 2.47 years with the 
youngest age exposed to retinoblastoma was 
2 months and the oldest age was 8 years. The 
results of this study are not much different 
from the research Youssef et al, that the 
occurrence of retinoblastoma most in the age 
range 3-48 months. Skuta et al states that 
about 90% of retinoblastoma cases are 
diagnosed in patients younger than 3 years. 
Shields et al describes retinoblastoma 
generally manifests at the age of the first 3 
years of life. The average age at diagnosis is 
related to family history and laterality of the 
disease. Patients with a family history of 
retinoblastoma are commonly diagnosed at 4 
months of age, patients with bilateral 
retinoblastoma are diagnosed at 12 months of 
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age and patients with unilateral 
retinoblastoma are diagnosed at 24 months of 
age.1,2,9,12 
Assessed in terms of tumor laterality, 
retinoblastoma generally occurs unilaterally. 
In this study, 88.47% of samples were 
classified as unilateral retinoblastoma and 
10.53% were bilateral retinoblastoma. This is 
supported by Youssef et al reporting as many 
as 87.5% of unilateral cases.1,2,12 In addition, 
the age of patients with bilateral 
retinoblastoma in this study was 0 and 1 years 
(samples 3 and 9), so the data this is 
supported by a report from Skuta et al as 
mentioned in the previous discussion.2 When 
we examine theoretically, in 60-70% of cases 
are sporadic and non-hereditary due to 
somatic mutations clinically representing 
unilateral retinoblastoma. The rest (30-40%) 
are hereditary due to germinal mutation rates 
that cause bilateral retinoblastoma. In the 
results of this study, there were 2 bilateral 
retinoblastoma patients shown in samples 
no.3 and 9 with younger ages (0 and 1 years). 
2,6,9,12 
 
Sample Histopathological Feature 
In this study, the paraffin preparation of the 
retinoblastoma tissue block subjects stored in 
the Pattern Anatomy Pathology Department 
of RSMH Palembang was made in 4 
micrometer thick pieces then painted with C-
kit primary antibody ready to use by 
immunohistochemical technique. The degree 
of differentiation is then read under a 
microscope to observe various 
histopathologic features in the sample tissue. 
Assessment of degree of differentiation is 
done by observing the criteria for well-
differentiated focus of Flexner-Wintersteiner 
rosettes or fleurettes, moderately 
differentiated in isolated Homer-Wright 
rosettes, whereas for the category of poorly 
differentiated in the absence of the above-
mentioned structures. On examination of 
electron microscopy, Flexner-Wintersteiner 
rosettes describes primitive photoreceptor 
cells. Furthermore, the lumen rosette 
describes the same staining pattern as stem 
cells and cones, indicating that Flexner-
Wintersteiner rosettes represents a specific 
form of retinal differentiation.39 In this study, 
results were similar to those of Youssef et al 
(2014) reported that 48.2% of the samples 
were stratified in moderate differentiation, 
followed by 35.7% with poorly differentiated 
and 16.1% of well differentiated.1 
Retinoblastoma samples at RSMH 
Palembang showed differentiated 
histopathology differiated by 68.42%, 
followed by both differentiated and poorly 
differentiated which have the same 
percentage, that is 15.79% respectively. 
Differences were reported by Barry et al in 
2007 of 63 cases, 7.94% belonging to well 
differentiated categories, 31.75% were 
moderately differentiated, and 60.32% or 38 
out of 63 cases were poorly differentiated. 10 
Several factors may be the cause of this 
difference, including sample age. Younger 
age is usually the degree of differentiation is 
still good or medium, while at an older age 
the degree of differentiation tends to be 
worse. Eagle et al explained that 
retinoblastoma with older age tends to be 
poorly differentiated, while more rosettes are 
clearly visible in younger children.25,37 In a 
study conducted at RSMH Palembang, there 
were three samples with degrees 
differentiated poorly differentiated with older 
age (samples no.2, no.5 and no.16). 
In this study, also reported the results of 
invasion of retinoblastoma to optic nerve and 
sclera, respectively as much as 63.16% and 
57.89%. This is almost similar to that of 
Youssef et al who reported that 46.4% of the 
sample had an invasion to the optic nerve and 
62.5% of the samples had an invasion of the 
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sclera. In this study there are also 3 cases 
reported difficult to determine the level of 
invasion (samples no.8, no.12 and no.18). 
This may be due to the difficult optical nerve 
structure identified in histopathologic 
preparations. Laurie et al reported that 
invasion of retinoblastoma into the optic 
nerve may be caused by several changes 
related to cadherin- mediated adhesion of 
cells.38,39 
Expression of C-kit on Different Degrees 
of Histopathology Differentiation and 
Retinoblastoma Invasion 
 
In this study, we used positive C-kit 
controls on GIST (Gastrointestinal Stromal 
Tumors) with very high positivity (90-95%) 
and even other literature mentioned 100%. 
The role of C-kit has been found in more than 
120 types of tumors by using 
immunohistochemical methods on TMA 
(tissue microarray). C-kit is generally found 
to be positive in GIST (100%), seminomas 
(84%), and adenoid-cystic carcinomas (65%) 
and in some other tumors also found positive 
C-kit expression, as well as retinoblastoma 
but in percentages smaller. 1,10,11,13-15 
Sengupta et al reported that 
immunohistochemistry can confirm 
retinoblastoma by identifying photoreceptors 
and glial cells, but the exact mechanism 
remains unclear.37 
Bosch et al (2005) conducted a study 
of immunostaining with C-kit antibodies in 
73 retinoblastoma cases and was found to be 
positive in 14 cases of 19.2%, then re-
classified as positive weak, moderate and 
strongly positive.11 In this study C-kit 
expression was positive as much as 63,16%. 
This percentage is slightly larger than 
previous research conducted by Barry et al 
with a 52.38% positive C-kit expression on 
retinoblastoma and followed by Youssef et al 
of 48.2%. Bosch et al reported 19.2% of 
positive C-kit expression in retinoblastoma. 
This may occur due to Bosch et al's research 
using TMA (tissue microarray analysis) 
which includes 3500 paraffin-embedded 
tumor samples for 120 tumor types so that 
only a small fraction (0.6 mm diameter) in 
each specimen compared to standard 
preparations. It may be possible that some 
areas of tumor belonging to the TMA can be 
negative while other areas may be 
positive.1,11,15 
In this study, the results of positive C-
kit expression were classified based on 
differentiation degrees of well-differentiated 
(25.0%), moderately differentiated (50.0%) 
and poorly differentiated (25.0%). This is 
supported by Youssef et al research obtained 
positive C-kit expression results in 20 of 36 
degrees of differentiation of well and 
moderate as much as 55.6%. In the case of 
poorly differentiated obtained 35.0%. This is 
almost similar to Barry et al described 
positive C-kit expression in 14 of 25 
moderate and well differentiated samples 
(56%) and 19 of 38 poorly differentiated 
(50%).11  
The factors that may affect the 
positivity of C-kit expression results are 
tissue handling or whether there is a history 
of preoperative chemotherapy may affect the 
reading outcome. In this study, it can not be 
known the overall history of patient's 
chemotherapy whether pre-operative or not, 
this is due to incomplete medical record data. 
However, in 1 patient recorded the sample # 
15 had a history of preoperative 
chemotherapy and obtained negative C-kit 
expression results. This is supported by a 
study by Youssef et al (2014) describing that 
patients undergoing preoperative 
chemotherapy may influence the 
interpretation of immunohistochemical 
results. Barry et al (2007) explains that 
immunohistochemical results are highly 
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dependent on specific techniques in tissue 
fixation used by each laboratory.1,10,40 
Invasion is one of the things that need 
to be observed in cases of retinoblastoma. 
The histopathologically observed invasion 
features are represented by the criterion that 
there is an invasion of the optic nerve if tumor 
cells can be identified behind the cribrosa 
lamina and sclera invasion when tumor cells 
have infiltrated Bruch's membrane. Research 
conducted by Youssef et al (2014) describes 
tumor growth patterns in the presence of 
invasion into the optic nerve showing 
significant positive C-kit expression. It is 
concluded that C-kit represents a more 
aggressive retinoblastoma of growth with 
extensive invasion.1 
Barry et al reported that of 33 samples 
with positive C-kit expression there were 31 
samples showing an invasion image to the 
sclera and / or optic nerve. In this study, 
samples with positive C-kit showed 6 of 12 
samples (50%) experienced invasion of the 
optic nerve and 7 of 12 samples (58.33%) 
experienced invasion of the sclera. Both of 
these studies provide a similar picture, ie 
most of the positive C-kit samples have a 
good invasion of the optic nerve and the 
sclera. These two networks are structurally 
very close to the retina so invasion of this 
tissue can help assess the severity of 
retinoblastoma and invasion of tumor cells 
into other tissues. The increased expression 
of this protein is due to uncontrolled spread 
of tumor cells to surrounding tissue.10 This 
study has some limitations such as the limited 
number of samples contained in Mohammad 
Hoesin Palembang General Hospital, 
incomplete medical record data so as not to 
connect clinical complaints with 
histopathologic picture in more detail. 
Because of the limited number of 
retinoblastoma cases results in uneven 
distribution of proportionally each degree of 






The degree of differentiation of 
retinoblastoma in this study is mostly in 
moderately differentiated category. The 
invasion of retinoblastoma to the optic nerve 
and sclera based on observations of 
histopathologic preparations. C-kit was 
expressed in most of retinoblastoma samples. 
It is necessary to do further research with 
larger number of samples with different 
degrees of retinoblastoma histopathologic 
differentiation to determine the association of 
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